Abstract
If we can visualize the epileptogenic lesion, the intractable epilepsy might be cured by the resective surgery. PET is a common clinical imaging tool, and it can evaluate and visualize brain function quantitatively and multidimensionally with various radio ligands. (18) FDG-PET and (11) C-flumazenil-PET are mainly used in the clinical settings, and they showed the decrease of glucose metabolism and binding in the epilepsy focus. In this decade, many PET radio-ligands are developed for positive imaging of epileptogenic lesion. The first target is neuroinflammation, such as 18 kDa-translocator protein (TSPO). (11) PK-11195-PET showed increase of TSPO binding in the focus in animal model, however, this alteration is unclear in human clinical study. Glutamate receptors are believed to be a novel biomarkers of epileptogenesis in future, and our experimental study showed the possibility that it could be a positive marker. Furthermore, other PET studies for neurotransmitters reported the role of opioids, cannabinoids, acetylcholine, and dopamine in modulating neuronal hyperexcitability. PET has the possibility not only to visualize the epileptic foci, but also elucidate of the mechanism of epileptogenesis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
